Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5 mg Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5 mg Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5 mg Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5 mg Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
